ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Pulmonary Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,139Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 277

$1.18M Total Retail Price of All Prescriptions

Rank: 6 out of 277

574 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
70% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 574 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

3% of this provider’s 574 patients filled at least one prescription for a schedule three drug, compared to an average of 1%.

Risky Drugs to Seniors

2% of this provider’s 16,554 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

35% of this provider’s prescriptions were for brand-name drugs, compared to an average of 56%.

Prescription Price

$65 was the average price of a prescription from this provider, compared to $137 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
OMEPRAZOLE 811 757 1 9
SIMVASTATIN 618 589 2 5
LEVOTHYROXINE SODIUM 611 557 3 11
AMLODIPINE BESYLATE 506 470 4 7
METFORMIN HCL 475 434 5 15
DIOVAN HCT 453 418 6 40
CARVEDILOL 368 341 7 28
NEXIUM 361 331 8 21
ZOLPIDEM TARTRATE 333 307 9 16
ATORVASTATIN CALCIUM 329 319 10 14
ATENOLOL 308 299 11 42
GLIMEPIRIDE 300 285 12 41
FUROSEMIDE 287 278 13 8
METOPROLOL SUCCINATE 285 258 14 23
PRAVASTATIN SODIUM 244 235 15 39
LISINOPRIL 234 186 16 20
AMLODIPINE BESYLATE-BENAZEPRIL 224 224 17 61
ALENDRONATE SODIUM 221 214 18 52
CRESTOR 221 210 18 25
TAMSULOSIN HCL 206 193 20 47
PROAIR HFA 205 198 21 3
LISINOPRIL-HYDROCHLOROTHIAZIDE 199 191 22 63
NAMENDA 187 182 23 51
DIOVAN 186 171 24 24
METOPROLOL TARTRATE 184 152 25 13
ADVAIR DISKUS 183 172 26 2
LOSARTAN POTASSIUM 180 163 27 35
ALBUTEROL SULFATE 163 93 28 45
SERTRALINE HCL 157 152 29 48
LOSARTAN-HYDROCHLOROTHIAZIDE 153 135 30 74
IBUPROFEN 149 133 31 78
WARFARIN SODIUM 144 131 32 18
EXELON 143 143 33 136
AZITHROMYCIN 140 128 34 12
DONEPEZIL HCL 139 139 35 32
LIPITOR 127 121 36 78
CLOPIDOGREL 126 123 37 26
PLAVIX 119 114 38 38
CLONIDINE HCL 119 103 38 58
LOVAZA 117 94 40 65
POTASSIUM CHLORIDE 113 113 41 31
LIDODERM 111 111 42 49
RAMIPRIL 111 98 42 60
PREDNISONE 109 99 44 4
LACTULOSE 106 89 45 67
CLOTRIMAZOLE-BETAMETHASONE 103 97 46 72
IPRATROPIUM BROMIDE 102 38 47 89
TRAMADOL HCL 102 88 47 34
ISOSORBIDE MONONITRATE ER 101 101 49 68
NAPROXEN 95 94 50 81
GLYBURIDE-METFORMIN HCL 94 88 R 51 125
JANUVIA 93 92 52 50
VOLTAREN 92 80 53 97
GABAPENTIN 89 76 54 44
SINGULAIR 89 80 54 6
ATENOLOL-CHLORTHALIDONE 88 88 56 203
MECLIZINE HCL 87 83 57 101
HYDROCHLOROTHIAZIDE 84 77 58 30
ONGLYZA 77 72 59 166
FLUTICASONE PROPIONATE 76 68 60 19
DIGOXIN 75 75 61 53
VENTOLIN HFA 75 71 61 27
BYSTOLIC 74 69 63 117
NATEGLINIDE 74 69 63 157
LEVOCETIRIZINE DIHYDROCHLORIDE 73 71 65 82
PAROXETINE HCL 71 70 66 122
METFORMIN HCL ER 70 62 67 123
RANITIDINE HCL 69 60 68 113
ENALAPRIL MALEATE 67 58 69 29
TRAMADOL HCL-ACETAMINOPHEN 66 59 70 142
ESCITALOPRAM OXALATE 66 65 70 59
OXYCODONE-ACETAMINOPHEN 65 32 S2 72 37
CIPROFLOXACIN HCL 63 60 73 94
VALSARTAN-HYDROCHLOROTHIAZIDE 62 61 74 179
WELCHOL 62 42 74 125
DIVALPROEX SODIUM 61 55 76 78
AMIODARONE HCL 61 61 76 159
MELOXICAM 58 54 78 56
ZETIA 57 57 79 85
EXFORGE HCT 56 55 80 242
SYNTHROID 56 56 80 87
ENABLEX 53 44 82 184
BENICAR HCT 52 52 83 253
PANTOPRAZOLE SODIUM 52 52 83 43
LANSOPRAZOLE 51 51 85 166
GLIPIZIDE 51 51 85 77
ISOSORBIDE DINITRATE 50 50 87 264
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 6, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.